These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 20551724

  • 1. Pain response profile of patients with fibromyalgia treated with duloxetine.
    Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ.
    Clin J Pain; 2010; 26(6):498-504. PubMed ID: 20551724
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS.
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [Abstract] [Full Text] [Related]

  • 4. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Jun; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 5. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
    Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.
    Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM, Zhang S, Pangallo BA.
    Clin J Pain; 2012 Jun; 28(9):775-81. PubMed ID: 22971669
    [Abstract] [Full Text] [Related]

  • 7. Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia.
    Wang F, Ruberg SJ, Gaynor PJ, Heinloth AN, Arnold LM.
    J Pain; 2011 Oct; 12(10):1088-94. PubMed ID: 21763211
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Oct; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 9. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD.
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [Abstract] [Full Text] [Related]

  • 10. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonja M.
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 12. Estimation of minimum clinically important difference for pain in fibromyalgia.
    Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, Kajdasz DK, Walker DJ, Chappell AS.
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):821-6. PubMed ID: 21312349
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 14. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
    Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S.
    Curr Med Res Opin; 2012 Jan 04; 28(1):41-8. PubMed ID: 22126422
    [Abstract] [Full Text] [Related]

  • 15. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
    Ziegler D, Pritchett YL, Wang F, Desaiah D, Robinson MJ, Hall JA, Chappell AS.
    Diabetes Care; 2007 Mar 04; 30(3):664-9. PubMed ID: 17327338
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Skljarevski V, Desaiah D, Zhang Q, Chappell AS, Detke MJ, Gross JL, Ziegler D.
    Diabetes Metab Res Rev; 2009 Oct 04; 25(7):623-31. PubMed ID: 19637208
    [Abstract] [Full Text] [Related]

  • 17. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
    Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A.
    J Pain; 2010 Feb 04; 11(2):109-18. PubMed ID: 19665938
    [Abstract] [Full Text] [Related]

  • 18. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Feb 04; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 19. Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
    Fava M, Detke MJ, Balestrieri M, Wang F, Raskin J, Perahia D.
    J Psychiatr Res; 2006 Jun 04; 40(4):328-36. PubMed ID: 16678205
    [Abstract] [Full Text] [Related]

  • 20. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ.
    Depress Anxiety; 2005 Jun 04; 21(4):170-7. PubMed ID: 16035056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.